Category: MS Drug Therapies

Patient Experiences with the Impacts of Multiple Sclerosis & Disease-Modifying Therapies

Bari Talente,1 Lisbet T Finseth,1 Natalie Blake,2 Kathleen Costello,3 Hollie Schmidt,4 Joe Vandigo,5 Elisabeth M Oehrlein5 1National Multiple Sclerosis Society, Washington, DC, USA; 2Multiple Sclerosis Foundation, Fort…

Stuart Schlossman

Featured image for “ACTRIMS 2025: Tolebrutinib impact greater in MS patients with PRLs”

ACTRIMS 2025: Tolebrutinib impact greater in MS patients with PRLs

Treatment candidate found effective in reducing disability progression risk by Andrea Lobo, PhD | March 5, 2025 — #ACTRIMS Sanofi’s experimental BTK inhibitor tolebrutinib is…

Stuart Schlossman

Featured image for ““The Immune System and MS Forum” – EASY Learning”

“The Immune System and MS Forum” – EASY Learning

Watch and Listen as MS Neurologists, Ben Thrower, MD and Aaron Boster, MD accurately and easily describe Multiple Sclerosis and…

Stuart Schlossman

Featured image for “Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication – FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis”

Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication – FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

Treat immediately if symptoms worsen or do not go away shortly after an injection [Posted 01/22/2025] — FDA.GOV AUDIENCE: Patient, Caregiver,…

Stuart Schlossman

Learning more about MS and Rare Autoimmune Diseases like NMOSD and MOGAD

#NMOSD #MOGAD #MS #autoimmune #raredisease…

Stuart Schlossman

Featured image for “Town Hall Meeting – New Frontier of Multiple Sclerosis, treatments and more”

Town Hall Meeting – New Frontier of Multiple Sclerosis, treatments and more

Listen and learn with Dr. Aaron Boster, MD #Sanofi #Sandoz…

Stuart Schlossman

Featured image for “Yes, I LIVE and BREATHE MULTIPLE SCLEROSIS”

Yes, I LIVE and BREATHE MULTIPLE SCLEROSIS

I found a way to overcome the grief of learning my condition in 1998, and turned it into a positive…

Stuart Schlossman

A LOOK at Holistic & Mainstream Approaches to Multiple Sclerosis

No excerpt…

Stuart Schlossman

Featured image for “Treating Multiple Sclerosis: Are They Doing It Wrong?”

Treating Multiple Sclerosis: Are They Doing It Wrong?

@AaronBosterMD Click red box to activate this video…

Stuart Schlossman

PRESS RELEASE : Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Paris, December 13, 2024. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of…

Stuart Schlossman

Categories

Latest Blog Posts